Marlous van der Hooft In radiopharma, GMP compliance is the baseline. But what truly differentiates high-performing organizations isn’t just adherence to regulations—it’s the ability to embed trust into every layer of the GMP system. At Qualificiency Consulting, we believe GMP should be more than a checklist. It should be a culture of reliability, where systems support processes, and processes empower people. Why Trust Matters in GMP Radiopharmaceuticals operate under extreme constraints: short half-lives, complex logistics, and high regulatory scrutiny. In this environment, trust isn’t optional—it’s operational. Trust enables: Faster decision-making in time-critical production Cross-functional alignment between QA, production, and planning Resilience when deviations or unexpected events occur But trust doesn’t happen by accident. It must be designed into the system. Three Ways We Help Firms Build Trust into GMP Systems 1. Transparency Protocols We help teams implement structured trans

Marlous van der Hooft In radiopharma, what makes a facility truly successful isn’t visible in the walls—it’s in the workflows. The invisible foundation of compliant, efficient, and scalable processes is what determines whether a site thrives or struggles. At Qualificiency, we’ve seen it too often: a facility design is already on paper, sometimes even under construction, and then we’re called in to “make it work.” Retrofitting processes into a pre-defined layout is like trying to choreograph a ballet on a stage built for a rock concert. It costs time, money, and—most critically—compliance. From Engineering to Emotion: A Deeper Understanding of Radiopharma In our previous blog, we explored how radiopharma is more than engineering—it’s emotion, regulation, and precision. The booming theranostics market is full of promise, but also full of pitfalls for those who underestimate the complexity of GMP and radiation safety. What sets Qualificiency apart is not just technical expertise, but live

Understanding Security in Radioprotection Uwe Saathoff Germany’s regulatory landscape for ionizing radiation is comprehensive. It includes the Radiation Protection Act (Strahlenschutzgesetz), the Radiation Protection Ordinance (Strahlenschutzverordnung), DIN standards, and guidance from the Strahlenschutzkommission. These frameworks are designed to protect people and the environment from the harmful effects of radioactive substances. However, most of these regulations focus on safe handling — from procurement and storage to processing and transport. In 2020, a new directive added a layer of security: the SEWD Directive. What Is the SEWD Directive? The SEWD Directive, officially titled “Guideline for Protection Against Interference or Other Third-Party Actions During Handling and Transport of Radioactive Substances”, was issued by the Federal Ministry for the Environment (BMUV). Its purpose is clear: to prevent the criminal release or theft of radioactive materials — either on-site or d

Marlous van der Hooft When a new product category emerges, it sparks excitement and innovation. But as the market matures, the rules of the game change—and companies that don’t adapt risk being left behind. At Qualificiency Consulting, we help radiopharma companies stay ahead by understanding where they are in the market lifecycle—and where they need to go next. The Four Stages of Market Maturity 1. Engineering-Driven Market: The Age of Invention Innovation is king. Products are new, exciting, and scarce. Customers buy because they want access to something novel. The market is driven by technical excellence—who can invent the next big thing? Think of the early days of theranostics or alpha emitters. The focus was on what the product could do, not how it was delivered or priced. 2. Manufacturing-Driven Market: The Race to Scale As demand grows, the challenge shifts from invention to production and distribution. Customers now ask: “Who can deliver this product fast, reliably, and complia